- Regulatory Status
- RUO
- Other Names
- Glycoprotein 120, Envelope Glycoprotein Gp120, gp120
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Recombinant Human CD4 binds to immobilized HIV GP120 in a dose-dependent manner. ED50 is between 3.5 – 21 ng/mL. -
Stability Testing for recombinant HIV GP120. Recombinant HIV GP120 was aliquoted in PBS, pH 7.2 at 0.2 mg/mL and one aliquot was kept at 4°C (Control), and another was frozen and thawed four times (4x Freeze/Thaw). After this procedure, the samples were tested for their ability in a binding assay with recombinant human CD4. The ED50 is between 3.5 – 21 ng/mL.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 719854 | 25 µg | 176€ | ||||
| 719856 | 100 µg | 380€ | ||||
Human immunodeficiency virus (HIV) envelope glycoprotein GP120 is derived from the proteolytic cleavage of GP160. GP120 plays a key role in the virus's ability to infect host cells. HIV infection is initiated by attaching to the surface receptor CD4 of the host lymphoid cells through GP120. The binding of GP120 to CD4 triggers a conformational change that enables it to interact with chemokine co-receptors like CCR5 or CXCR4. This structural rearrangement is required for GP41 anchoring to the cell membrane, which facilitates HIV entry into CD4+ T helper cells. GP120 also serves as a ligand for DC-SIGN/CD209, which is highly expressed on the dendritic cells (DC) surface. DC-SIGN not only acts as a receptor for viral entry into DCs, but it also facilitates HIV transport to secondary lymphoid organs rich in T cells, enhancing infection in trans of these targets.
Product DetailsProduct Details
- Source
- Recombinant HIV GP120, amino acid Leu33-Arg509 (Accession: #Q03805), with a C-terminal 6-His tag was expressed in 293E.
- Molecular Mass
- The 483 amino acid recombinant protein has a predicted molecular mass of approximately 54.41 kD. The DTT-reduced and non-reduced proteins migrate at approximately 70 - 120 kD and > 140 kD by SDS-PAGE, respectively. The predicted N-terminal amino acid is Leu.
- Purity
- > 95 %, as determined by Coomassie-stained SDS-PAGE
- Formulation
- 0.22 µm filtered protein solution is in PBS, pH 7.2
- Endotoxin Level
- Less than 0.1 EU per µg of cytokine as determined by the LAL method
- Concentration
- 25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin the vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 μg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Activity
- When recombinant HIV GP120 is immobilized at 1 µg/mL, recombinant human CD4 (Cat. No. 569604/569606) binds in a dose-dependent manner with ED50 range of 3.5 – 21 ng/mL.
- Application
-
Biossay
- Application Notes
-
Application Notes BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.
Antigen Details
- Structure
- Dimer
- Distribution
-
Human immunodeficiency virus 1 (HIV-1)
- Function
- Binds to the cell-surface receptor CD4, initiating HIV-1 infection
- Interaction
- T helper cells, Dendritic cells
- Ligand/Receptor
- CD4, CXCR4 (co-receptor), CCR5 (co-receptor), DC-SIGN
- Bioactivity
- The bioactivity was measured by immobilized recombinant HIV GP120 binding recombinant human CD4 in a dose-dependent manner using a functional ELISA.
- Biology Area
- Bacterial proteins and Toxins, Cell Biology, Signal Transduction
- Antigen References
-
- Chen B. 2019. Trends Microbiol. 27:878-891.
- Yoon V, et al. 2010. Curr Med Chem. 17:741-9.
- Li W, et al. 2023. Nature. 623:1026-1033.
- Geijtenbeek TB, et al. 2000. Cell. 100:587-97.
- Wyatt R, et al. 1998. Science. 280:1884-8.
- Blumenthal R, et al. 2012. J Biol Chem. 287:40841-9.
- Gene ID
- NA
- UniProt
- View information about GP120 on UniProt.org
Related Pages & Pathways
Pages
Related FAQs
- Why choose BioLegend recombinant proteins?
-
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins. - How does the activity of your recombinant proteins compare to competitors?
-
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
-
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
-
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
-
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
-
Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)
Login / Register 



Follow Us